Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Youersheng Pharmaceutical is a prominent biotechnology company headquartered in Wuhan, China, primarily recognized for its extensive portfolio of life science research reagents. Operating globally under the brands Cloud-Clone and USCN Life Science, the company specializes in the research, development, and large-scale production of ELISA kits, CLIA kits, monoclonal and polyclonal antibodies, and recombinant proteins. Their product catalog encompasses thousands of specific targets, supporting academic and industrial research in fields such as oncology, immunology, cardiovascular disease, and endocrinology. The company maintains advanced R&D centers and manufacturing facilities that adhere to rigorous quality control standards to serve the international scientific community. In addition to reagents, they provide custom services for protein expression and antibody preparation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Youersheng Pharmaceutical.